Nickel Or Cobalt Patents (Class 514/501)
-
Patent number: 6759544Abstract: Complex compounds containing acesulfame have good antimicrobial action, in particular antibacterial action, and are distinguished by the fact that they are complex compounds of metallic elements such as zinc, copper, silver, or nonmetallic quaternary ammonium cations, such as the cetylpyridinium cation, with acesulfame. The invention also relates to a process for preparing the compounds and their use in the oral hygiene sector.Type: GrantFiled: June 7, 2002Date of Patent: July 6, 2004Assignee: Nutrinova Nutrition Specialties & Food Ingredients GmbHInventor: Andreas Burgard
-
Patent number: 6746523Abstract: A composition for protecting wood from weathering which comprises the complex from an acidic water soluble metal salt combined with fatty amine in a weight ratio of from 1 to 10 to 10 to 1 metal salt to fatty amine wherein the metal salt is chosen from the group comprising cobalt, iron, manganese, nickel, and silver. The composition may contain a nonionic or cationic pesticide.Type: GrantFiled: April 14, 2003Date of Patent: June 8, 2004Inventor: Michael Howard West
-
Patent number: 6710079Abstract: A composition and method of preparing amino acid chelates and complexes free of interfering ions by blending an amino acid ligand, a calcium oxide and/or hydroxide, and a hydrated metal sulfate salt, placing the blend in a closed environment, heating the blend, and allowing the blend to react is disclosed and described. By heating at low to moderate temperatures in an enclosed environment, the waters of hydration of the metal salt are retained in the enclosed environment and serve to provide the moisture necessary to enable a bonding reaction to take place between the electron rich functional groups of the ligand and the metal ion of the hydrated metal sulfate salt. Additionally, calcium sulfate is formed which can be maintained in the final product.Type: GrantFiled: October 11, 2000Date of Patent: March 23, 2004Assignee: Albion International, Inc.Inventors: H. DeWayne Ashmead, Stephen D. Ashmead, David C. Wheelwright, Clayton Ericson, Mark Pedersen
-
Patent number: 6706764Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.Type: GrantFiled: May 7, 1997Date of Patent: March 16, 2004Assignees: Avicena Group, Inc., The General Hospital CorporationInventors: Rima Kaddurah-Daouk, Ghaleb Daouk, M. Flint Beal
-
Patent number: 6677385Abstract: Methods and compositions for reactions of hydrogen over a Re-containing catalyst with compositions containing a 5-carbon sugar, sugar alcohol, or lactic acid are described. It has been surprisingly discovered that reaction with hydrogen over a Re-containing multimetallic catalyst resulted in superior conversion and selectivity to desired products such as propylene glycol. A process for the synthesis of PG from lactate or lactic acid is also described.Type: GrantFiled: August 6, 2002Date of Patent: January 13, 2004Assignee: Battelle Memorial InstituteInventors: Todd A. Werpy, John G. Frye, Jr., Alan H. Zacher, Dennis J. Miller
-
Publication number: 20030216371Abstract: The invention provides antioxidant salen-metal complexes, compositions of such antioxidant salen-metal complexes having superoxide activity, catalase activity, and/or peroxidase activity, compositions of salen-metal complexes in a form suitable for pharmaceutical administration to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide, and cosmetic and free radical quenching formulations of salen metal compounds.Type: ApplicationFiled: May 30, 2003Publication date: November 20, 2003Inventors: Bernard Malfroy-Camine, Susan Robin Doctrow
-
Patent number: 6649783Abstract: Compositions comprising (±)-2-((dimethylamino)methyl)cyclohexanone, a transition-metal salt, and an organic solvent and methods of preparing (±)-cis-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols, in particular (±)-cis-2-((dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol, are disclosed herein. In one embodiment, the (±)-2-((dimethylamino)methyl)cyclohexanone and transition-metal salt are in the form of a (±)-2-((dimethylamino)methyl)cyclohexanone:transition-metal salt complex. In another embodimemt, aryl is 3-methoxyphenyl.Type: GrantFiled: October 3, 2001Date of Patent: November 18, 2003Assignee: Euro-Celtique, S.A.Inventors: Robert J. Kupper, Andreas Stumpf
-
Patent number: 6630172Abstract: Disinfectant formulations are described which are preferably ecologically friendly and non-toxic to mammals and plants, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having at least one metal ion which is microbicidal to at least one microorganism and potassium sodium tartrate in some form. When potassium sodium tartrate is used with these metal ions, it enhances the complex-forming properties of such metal complexes while concurrently increases their efficacy and potency at the same level of metal ion concentrations. These microbicidal formulations can be diluted in suitable proportions into aqueous systems to produce the desired dosages for each individual case, depending on the level and the severity of the contamination. The microbicidal formulations can be applied by conventional methods, e.g., spraying, soaking, fogging, impregnation, and the like.Type: GrantFiled: January 22, 2001Date of Patent: October 7, 2003Inventor: Kareem I. Batarseh
-
Publication number: 20030180381Abstract: Cobalt salts have been found to be particularly effective against H. pylori and may therefore be used to treat gastroin tenstinal infection with this bacteria. The cobalt salts have the advantage of showing a good degree of selectivity for H. pylori over other Gram positive and Gram negative bacteria. Treatment with the cobalt salts may be carried out at the same time as conventional treatment with an antibiotic and/or a proton pump inhibitor.Type: ApplicationFiled: February 10, 2003Publication date: September 25, 2003Inventors: Sylvaine Franciose Aline Bruggraber, Jonathan Joseph Powell
-
Patent number: 6596733Abstract: Nitric oxide scavengers, such as dithiocarbamate-containing compounds, are used to reduce side effects caused by therapeutic administration of nitric oxide sources by administering the nitric oxide scavenger(s) to the subject after the therapeutic effect of the nitric oxide source has been achieved. For example, the nitric oxide source can be coadministered with the nitric oxide scavenger, with the latter formulated in a time release vehicle selected to delay release of the scavenger for a period of time sufficient to ensure that the therapeutic goal of the nitric oxide source has been achieved before release of the scavenger. Formulations and kits, including a bubble pack with pairwise arrangement of unit doses of a desired nitric oxide source and nitric oxide scavenger, are also provided.Type: GrantFiled: July 24, 2001Date of Patent: July 22, 2003Assignee: Medinox, Inc.Inventor: Ching-San Lai
-
Patent number: 6579904Abstract: Betaine transition metal complexes are formed by: a) reacting a solution including an alkali metal salt of chloroacetic acid with a solution including the transition metal salt to give a solution including a chloroacetate transition metal complex; and b) reacting the solution including the chloroacetate transition metal complex with trimethylamine to give a solution including the betaine transition metal complex. Such betaine transition metal complexes may be used as a feed supplement for animals in the process of preparing such animals for market.Type: GrantFiled: September 22, 2000Date of Patent: June 17, 2003Assignee: K.E.R. Associates, Inc.Inventors: Harvey B. Hopps, Gary Culp, Steven B. Malcolm, Ken W. Ridenour, Jay Thurman
-
Patent number: 6573257Abstract: The invention provides antioxidant salen-metal complexes, compositions of such antioxidant salen-metal complexes having superoxide activity, catalase activity, and/or peroxidase activity, compositions of salen-metal complexes in a form suitable for pharmaceutical administration to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide, and cosmetic and free radical quenching formulations of salen metal compounds.Type: GrantFiled: April 4, 2000Date of Patent: June 3, 2003Assignee: Eukarion, Inc.Inventors: Bernard Malfroy-Camine, Susan Robin Doctrow
-
Patent number: 6521265Abstract: A method of arresting the flow of blood and other protein containing body fluids flowing from an open wound and for promoting wound healing. In the method, a substantially anhydrous compound of a salt ferrate is provided for a unique use which, when hydrated after mixing with a victim's own blood or other aqueous media, produces Fe+++ thereby promoting clotting when applied in a paste form to the wound for a time sufficient to arrest substantial further blood and other body fluid flow from the wound. The compound is formed of a ferrate (VI) salt taken from the group consisting of H, Li, Na, K, Rb, Cs and Fr. However, to decrease or eliminate stinging sensation, the compound may be formed having a ferrate (VI) salt taken from the group consisting of Be, Mg, Ca, Sr, Ba, Ra, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, In, Sn, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, TI, Pb, Bi, Al, As, NH4 and N(C4H9)4.Type: GrantFiled: June 13, 2000Date of Patent: February 18, 2003Assignee: Biolife, L.L.C.Inventor: James A. Patterson
-
Publication number: 20030008856Abstract: The use of transition metal complexes in the treatment of septic shock, in particular the hypotension associated therewith and pharmaceutical formulations comprising such complexes are disclosed. The use of such transition metal complexes in the treatment of other conditions caused by pathological NO production are also disclosed.Type: ApplicationFiled: August 6, 2002Publication date: January 9, 2003Inventors: Wieslaw Mieczyslaw Kazmierski, Luis Molina
-
Publication number: 20020161049Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.Type: ApplicationFiled: May 7, 1997Publication date: October 31, 2002Inventors: RIMA KADDURAH-DAOUK, GHALEB DAOUK, M. FLINT BEAL
-
Patent number: 6468657Abstract: Multilayered porous materials are formed by coating a porous substrate with a metal and adsorbing an organic layer comprising a recognition moiety onto the metal film. The recognition moiety interacts with an analyte of interest allowing for its detection, purification, etc. Suitable recognition moieties can be selected from a range of species including, small molecules, polymers and biomolecules and the like. The novel porous materials of the invention can be utilized in an array of methods including, ion-exchange, ion-selective ion-exchange, assays, affinity dialysis, size exclusion dialysis and the like.Type: GrantFiled: December 4, 1998Date of Patent: October 22, 2002Assignee: The Regents of the University of CaliforniaInventors: Zhizhong Hou, Pieter Stroeve, Nicholas Abbott
-
Patent number: 6426093Abstract: A biocidal composition composed of a ternary complex of a negatively-charged biocide, a transition metal ion and chelator has synergistic biocidal effects as compared with a composition of each of the components alone. The chelator is preferably a neutral or positively-charged chelator. The ternary complex may be used for killing or inhibiting the growth of living cells.Type: GrantFiled: February 9, 1999Date of Patent: July 30, 2002Assignee: Yissum Research Development Company of the Hebrew University of JerusalemInventors: Mordechai Chevion, Benzhan Zhu, Svetlana Schechtman
-
Patent number: 6423350Abstract: An inorganic antimicrobial composition has the formula AB2O4, wherein A and B are low temperature far infrared irradiating metals, A is Mg, Zn, Mn, Ni, Co, or Fe(II), B is Al, Cr(III), Mn(III) or Fe(III), and O is oxygen. An antimicrobial article is made by coating said composition on a porous honeycomb-shaped substrate. An organic antimicrobial article is made from a quaternary ammonium salt coated on a porous honeycomb-shaped substrate. Processes of making the antimicrobial articles are provided.Type: GrantFiled: February 7, 2001Date of Patent: July 23, 2002Assignee: Parker Holding Services Corp.Inventors: Yen-Kuen Shiau, Chung-Hsun Wu
-
Publication number: 20020091113Abstract: The use of transition metal complexes in the treatment of septic shock in particular the hypotension associated therewith and pharmaceutical formulations comprising such complexes are disclosed. The use of such transition metal complexes in the treatment of other conditions caused by pathological NO production are also disclosed.Type: ApplicationFiled: October 5, 2001Publication date: July 11, 2002Applicant: Molichem Medicines, Inc.Inventors: Wieslaw Mieczyslaw Kazmierski, Luis Molina
-
Patent number: 6417182Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.Type: GrantFiled: March 9, 2001Date of Patent: July 9, 2002Assignee: AnorMED Inc.Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
-
Patent number: 6407138Abstract: The present invention relates to compositions and methods of preparing amino acid chelates that are electrically neutral and free of interfering ions. The composition is prepared by reacting in an aqueous solution a calcium oxide and/or hydroxide, an amino acid, and a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the ions present in solution to react forming a metal amino acid chelate and an essentially inert calcium sulfate, and wherein the metal amino acid chelate has a ligand to metal molar ratio from 2:1 to 3:1.Type: GrantFiled: October 11, 2000Date of Patent: June 18, 2002Assignee: Albion International, Inc.Inventors: Stephen D. Ashmead, David C. Wheelwright, Clayton Ericson, Mark Pedersen
-
Patent number: 6387412Abstract: A storage stable magnesium oxychloride coated granular animal feed mineral supplement composition resistant to disintegration cause by moisture absorption and attrition, comprising granular mineral nutrients useful as animal feed supplements and magnesium oxychloride coatings amounting to between 0.5 and 10.0 percent of the weight of the granules, formed on the granules of mineral nutrients by coreaction of magnesium chloride and magnesium oxide. An additional coating of between 0.2 and 2.0 percent magnesium stearate formed on the magnesium oxychloride may be used to decrease the rate of wetting of the granular animal feed mineral supplements.Type: GrantFiled: April 14, 2000Date of Patent: May 14, 2002Assignee: Agri-Nutrients Technology Group, Inc.Inventor: William P. Moore
-
Patent number: 6337315Abstract: Anti-inflammatory compositions, well suited for a wide variety of therapeutic/cosmetic applications, comprise combinatory immixture of (1) an effective anti-inflammatory amount of at least one peptide derivative of &agr;-type melanocyte stimulating hormone (&agr;-MSH), or functional biological equivalent thereof, and (2) an effective anti-inflammatory response-enhancing amount of at least one marine algal extract.Type: GrantFiled: July 15, 1999Date of Patent: January 8, 2002Assignee: Societe L'Oreal S.A.Inventors: Yann Mahe, Nelly Billoni, Lionel Breton, Lien Bui-Bertrand
-
Patent number: 6323354Abstract: A method of preparing amino acid transition metal chelates a palatable highly bioavailable source of transition metals for animal nutrition from lipoproteins and transition metal salts. The method requires strong aqueous base hydrolysis of the lipoproteins to sodium or potassium salts of alpha amino acids mixed with fatty acids. The salts are neutralized to amino acids mixed with fatty acids before the aqueous mixture is reacted with transition metal salts to form aqueous chelates. The aqueous mixture is dried and granulated to form a dry product comprising transition metal chelates homogeneously mixed with fatty acids. The new granular composition containing zinc, iron, manganese, copper, cobalt, or chromium provides a palatable and highly bioavailable source of transition metals for animal nutrition. Effective sources of lipoproteins are fractured cell walls of microbes generated in biological syntheses.Type: GrantFiled: March 16, 2001Date of Patent: November 27, 2001Assignee: Agri-Nutrients Technology Group, Inc.Inventor: William P. Moore
-
Publication number: 20010043938Abstract: An inorganic antimicrobial composition has the formula AB2 O4, wherein A and B are low temperature far infrared irradiating metals, A is Mg, Zn, Mn, Ni, Co, or Fe(II), B is Al, Cr(III), Mn(III) or Fe(III), and O is oxygen. An antimicrobial article is made by coating said composition on a porous honeycomb-shaped substrate. An organic antimicrobial article is made from a quaternary ammonium salt coated on a porous honeycomb-shaped substrate. Processes of making the antimicrobial articles are provided.Type: ApplicationFiled: February 7, 2001Publication date: November 22, 2001Inventors: Yen-Kuen Shiau, Chung-Hsun Wu
-
Publication number: 20010041738Abstract: Acesulfame-metal complexes, formed from a trace element, preferably Fe, Zn, Cu, Mn, Co and 2 molecules of acesulfamic acid by precipitation reaction with the use of suitable salts, are distinguished by a pleasantly sweet taste and are therefore suitable as sweeteners, food supplements and for enrichment of food, medicaments and feeds with trace elements.Type: ApplicationFiled: March 16, 2001Publication date: November 15, 2001Inventor: Andreas Burgard
-
Patent number: 6316652Abstract: The invention relates to novel targeting drug agents that are targeted for entry into the mitochondria. More specifically, the agents are cisplatin derivatives called mitoplatins which are useful as anti-tumor agents. Mitoplatins are named for their targeting to the mitochondrial DNA via the carnitine-acylcarnitine translocase system. The invention also relates to methods of synthesizing mitoplatins, compositions of matter containing mitoplatins and methods of using the mitoplatins.Type: GrantFiled: June 6, 1995Date of Patent: November 13, 2001Inventor: Kosta Steliou
-
Patent number: 6284752Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localised high concentration of nitric oxide in the body.Type: GrantFiled: October 19, 1998Date of Patent: September 4, 2001Assignee: AnorMED Inc.Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
-
Patent number: 6270809Abstract: The invention provides methods for producing edible plant tissue biomasses suitable for use as nutritional supplements. The seedlings are exposed to at least one metal and normal seedling growth is interrupted prior to the eleventh day following germination to thereby produce a metal-enriched plant seedling tissue biomass. The metal-containing edible plant tissue biomasses are also provided.Type: GrantFiled: November 6, 1998Date of Patent: August 7, 2001Assignee: Phytotech Inc.,Inventors: Burt D. Ensley, Mark Elless, Michael J. Blaylock, Jianwei Huang
-
Patent number: 6265420Abstract: Nitric oxide scavengers, such as dithiocarbamate-containing compounds, are used to reduce side effects caused by therapeutic administration of nitric oxide sources by administering the nitric oxide scavenger(s) to the subject after the therapeutic effect of the nitric oxide source has been achieved. For example, the nitric oxide source can be coadministered with the nitric oxide scavenger, with the latter formulated in a time release vehicle selected to delay release of the scavenger for a period of time sufficient to ensure that the therapeutic goal of the nitric oxide source has been achieved before release of the scavenger. Formulations and kits, including a bubble pack with pairwise arrangement of unit doses of a desired nitric oxide source and nitric oxide scavenger, are also provided.Type: GrantFiled: June 23, 1998Date of Patent: July 24, 2001Assignee: Medinox, Inc.Inventor: Ching-San Lai
-
Patent number: 6255287Abstract: A method of preparing a product for treating livestock comprising providing as ingredients molasses, water, ethyl alcohol, chelated minerals, and at least a vitamin mix. The method includes the steps of mixing the ethyl alcohol and water first, then adding each of the remaining ingredients separately to the mixture of ethyl alcohol and water. The composition is then mixed until homogeneous to provide a liquid treatment which, when introduced into livestock, will reduce considerably the length of, and amount of, lot adaptation stress.Type: GrantFiled: February 16, 1996Date of Patent: July 3, 2001Assignee: Vit-E-Men Co., Inc.Inventors: Charles Watson, Scott Charles Watson, George G. Gentry
-
Patent number: 6251417Abstract: An inorganic antimicrobial composition has the formula AB2O4, wherein A and B are low temperature far infrared irradiating metals, A is Mg, Zn, Mn, Ni, Co, or Fe(II), B is Al, Cr(III), Mn(III) or Fe(III), and O is oxygen. An antimicrobial article is made by coating said composition on a porous honeycomb-shaped substrate. An organic antimicrobial article is made from a quarternary ammonium salt coated on a porous honeycomb-shaped substrate. Processes of making the antimicrobial articles are provided.Type: GrantFiled: July 19, 1999Date of Patent: June 26, 2001Inventors: Yen-Kuen Shiau, Chung-Hsun Wu
-
Patent number: 6245758Abstract: The present invention provides a method for the treatment of diseases by the decomposition of peroxynitrite, preferably decomposition to benign products, comprising the use of a complex which is a selected ligand structure providing a complexed metal such as Mn, Fe, Ni and V transition metals. The method of use, as well as novel pharmaceutical compositions therefor, are for the treatment of diseases advantageously affected by decomposition of peroxynitrite ed at a rate over the natural background rate of decay of peroxynitrite in humans suffering from the disease which comprises administration of an amount of a complex, in dosage unit form, which is effective for such acceleration of the decomposition of peroxynitrite .Type: GrantFiled: September 9, 1996Date of Patent: June 12, 2001Inventors: Michael K. Stern, Daniela Salvemini
-
Patent number: 6242009Abstract: Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having the formula R-M, wherein R is at least one organic chelating moiety and M is at least one metal ion which is microbicidal to at least one microorganism. These complexes can disrupt microorganism activities by penetrating the natural protecting bio-films of such microorganisms through the reaction of the R-group with the organic constituents of these microorganisms while releasing M into their intra-cellular media. Thus, this process exhibits its biocidal activities from the inside-out, contrary to other methods which rely on damaging the protective biofilms.Type: GrantFiled: April 20, 1999Date of Patent: June 5, 2001Inventors: Kareem I. Batarseh, Marwan Al-Kayed
-
Patent number: 6197815Abstract: Metal amino acid chelates for animals are beneficial for facilitating and promoting growth by increasing desired metallic ion uptake. The present invention is directed to a process for providing an animal fed additive by preparing metal amino acid chelates, and the metal amino acid chelate growth facilitator, promoter and enhancer prepared by the process.Type: GrantFiled: March 18, 1998Date of Patent: March 6, 2001Assignee: J.H. Biotech, Inc.Inventor: Hsinhung John Hsu
-
Patent number: 6146666Abstract: A Thiobacillus thiooxidans growth inhibitor containing as the active ingredient at least one substance selected from the group consisting of a tungsten powder and tungsten compounds. Under acidic conditions of pH value of 4 or less, this growth inhibitor sufficiently inhibits the growth of T. thiooxidans. When added in a very small amount to, for example, a structural material such as concrete in a sewage disposal plant, etc., it can therefore inhibit the growth of T. thiooxidans without substantially decreasing the strength, etc. of the structural material per se.Type: GrantFiled: May 26, 1998Date of Patent: November 14, 2000Assignee: Hazama CorporationInventors: Terunobu Maeda, Atsunori Negishi, Yasuo Nogami, Tsuyoshi Sugio
-
Patent number: 6114379Abstract: A chelate comprised of creatine bonded to an essential mineral selected from the group consisting of Mg, Ca, Cu, Zn, Fe, Cr, Co, Mo, Se and Mn to form a heterocyclic ring. Preferably, the metal is Mg, but Ca, Zn, Fe, Cr and Mn are also preferred. The creatine chelates of the present invention are capable of being absorbed in the stomach or intestines via active transport without substantial metabolism of the chelate. In other words, the creatine ligand is protected by the metal from undergoing cyclization in the acidic environment of the stomach and the metal is made more bioavailable due to the presence of the creatine ligand.Type: GrantFiled: July 7, 1999Date of Patent: September 5, 2000Assignee: Albion Laboratories, Inc.Inventors: David C. Wheelwright, Stephen D. Ashmead
-
Patent number: 6086923Abstract: The present invention is directed to a method of inhibiting the growth of disease organisms on and in plants by directly applying an aqueous solution comprising urea and at least one water-soluble salt of a divalent cation and a monovalent anion to the seeds, stems, bark, leaves, seed heads or sub-surface root zones of said plants. The weight percent ratio of urea to divalent cation in these solutions should be from about 0.25-10.0 to 1.0. Preferred divalent cations include those of the alkaline earth metals and the transition metals. Most preferred are calcium, magnesium, zinc, manganese, copper, iron, cobalt, nickel and mixtures thereof. Preferred anions include nitrate, chloride, bromide and mixtures thereof. In more preferred solutions, the ratio of urea to divalent cation is from about 2.0-7.0 to 1.0. Particularly preferred solutions include calcium chloride as the water-soluble salt. Optionally, a second water-soluble salt of a divalent cation and a monovalent anion may be included.Type: GrantFiled: March 31, 1997Date of Patent: July 11, 2000Assignee: Stoller Enterprises, Inc.Inventor: Jerry Herman Stoller
-
Patent number: 6075031Abstract: The present invention relates to the use of creatine compounds including cyclocreatine and creatine phosphate for treating or preventing a metabolic disorder consisting of hyperglycemia, insulin dependent diabetes mellitus, impaired glucose tolerance, hyperinsulinemia, insulin insensitivity, diabetes related diseases in a patient experiencing said disorder. The creatine compounds which can be used in the present method include (1) analogues of creatine which can act as substrates or substrate analogues for the enzyme creatine kinase; (2) compounds which can act as activators or inhibitors of creatine kinase; (3) compounds which can modulate the creatine transporter (4) N-phosphocreatine analogues bearing transferable or non-transferable moieties which mimic the N-phosphoryl group. (5) compounds which modify the association of creatine kinase with other cellular components.Type: GrantFiled: August 19, 1997Date of Patent: June 13, 2000Assignees: Dana-Farber Cancer Institute, Avicena Group, Inc.Inventors: Rima Kaddurah-Daouk, Beverly A. Teicher
-
Patent number: 6071908Abstract: A method of treating neoplastic disease wherein a patient in need of such treatment is administered an effective amount of a radiation-activated cytotoxin prodrug (RACP) which has low toxicity, which is reducible by reducing agents generated by the radiolysis of water and which, upon reduction, releases a sufficient amount of a cytotoxic effector of sufficient cytotoxic potency to kill tumor cells. The tumor cells are irradiated with ionizing radiation to reduce the prodrug which is present at the locus of the tumor cells to release the cytotoxic effector.Type: GrantFiled: May 7, 1998Date of Patent: June 6, 2000Assignee: Auckland Uniservices LimitedInventors: William A. Denny, Moena Tercel, William R. Wilson
-
Patent number: 6046188Abstract: The invention provides antioxidant salen-metal complexes, compositions of such antioxidant salen-metal complexes having superoxide activity, catalase activity, and/or peroxidase activity, compositions of salen-metal complexes in a form suitable for pharmaceutical administration to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide, and cosmetic and free radical quenching formulations of salen metal compounds.Type: GrantFiled: March 11, 1998Date of Patent: April 4, 2000Assignee: Eukarion, Inc.Inventors: Bernard Malfroy-Camine, Susan Robin Doctrow
-
Patent number: 6020369Abstract: Respiratory viral infections may be effectively prevented or treated by administering an aerosol spray comprising a polyoxometalate to the lungs.Type: GrantFiled: July 7, 1998Date of Patent: February 1, 2000Inventors: Raymond F. Schinazi, Craig L. Hill
-
Patent number: 6008190Abstract: The invention relates to novel cobalt compounds, having a general structure ##STR1## wherein Co is either Co(II) or Co(III), and each of the R groups is selected from the group consisting of hydrogen, alkyl, hydrophilic organic acid, alkyl amine, amine, alkyl alcohol, alcohol, polypeptide or nucleic acid. The invention further relates to methods of using such compounds to reduce the biological activity of proteins, particularly enzymes and zinc finger-containing proteins.Type: GrantFiled: December 12, 1995Date of Patent: December 28, 1999Assignee: California Institute of TechnologyInventors: Thomas J. Meade, Toshihiko Takeuchi, Harry B. Gray, Melvin Simon, Angelique Y. Louie
-
Patent number: 5929064Abstract: Amino acid complexes of cobalt (III) mesoporphyrin IX and cobalt (III) protoporphyrin IX are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as antiobesity agents and for the treatment of cyanide poisoning, neonatal hyperbilirubinemia, and cancer.Type: GrantFiled: February 2, 1998Date of Patent: July 27, 1999Assignee: Warner-Lambert CompanyInventors: Om P. Goel, Stephen J. Johnson, Lawrence D. Wise
-
Patent number: 5916356Abstract: This invention relates to preservative compositions which comprise a biocidal metal compound and an fungicidal compound containing a triazole group. Methods of treating wood with the composition are also described.Type: GrantFiled: June 2, 1997Date of Patent: June 29, 1999Assignee: Hickson International PLCInventors: Gareth Williams, Judith Ann Cornfield, Janet Brown, Neil Patrick Ryan
-
Patent number: 5886032Abstract: A method of treating an animal having a condition associated with the presence of cyanide in quantities sufficient to cause undesirable symptoms which comprises administering to the subject a compound in an amount effective to alleviate the undesirable symptoms, the compound having the structure: ##STR1## wherein R.sup.1 and R.sup.1' are the same or different and each is an alkyl group, a phenyl group or a substituted derivative of a phenyl group;R.sup.2 and R.sup.2' are the same or different and each is hydrogen, an unbranched alkyl group, a halide or a group having the structure R--C-- ##STR2## wherein R is hydrogen, an alkoxide group, and alkyl group or OH; R.sup.3 and R.sup.3' are the same or different and each is hydrogen or an alkyl group;X and X' are the same or different and each is a water-soluble group having weak to intermediate field strength; andQ.sup.- is a soluble, pharmaceutically acceptable negative ion.Type: GrantFiled: January 27, 1998Date of Patent: March 23, 1999Assignee: Redox Pharmaceutical CorporationInventors: David Gershon, Uri Taitelman
-
Patent number: 5880149Abstract: The invention relates to metal complexes used to bind proteins and enzymes.Type: GrantFiled: September 27, 1996Date of Patent: March 9, 1999Assignee: California Institute of TechnologyInventors: Mark W. Grinstaff, Harry B. Gray, Thomas J. Meade
-
Patent number: 5863911Abstract: Diarylethylene metallocene derivatives, processes for preparing the same and pharmaceutical compositions which contain the derivatives are disclosed. The compounds of the invention can exhibit anti-tumor activity, and can be particularly useful in the treatment of estrogen-dependent cancers.Type: GrantFiled: August 11, 1997Date of Patent: January 26, 1999Assignee: Modelisation et Mise au Point de Molecules MedicinalesInventors: Gerard Jaouen, Siden Top
-
Patent number: 5843997Abstract: The present invention provides novel compounds that affect excitatory amino acid receptors and are useful in the treatment of neurological disorders. This invention also provides synthetic methods for the preparation of the novel compounds.Type: GrantFiled: April 2, 1996Date of Patent: December 1, 1998Assignee: Eli Lilly and CompanyInventors: Lawrence J. Heinz, William H.W. Lunn, Darryle Darwin Schoepp
-
Patent number: 5824673Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.Type: GrantFiled: February 26, 1996Date of Patent: October 20, 1998Assignee: Johnson Matthey Public Limted CompanyInventors: Michael J. Abrams, Simon P. Fricker, Barry A. Murrer, Owen J. Vaughan